Faculty profile

Ur Metser

Back to faculty

ProfessorDepartment of Medical ImagingUniversity of Toronto

Ur Metser

Professor

Department of Medical Imaging

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
79 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

142

Publications

2,747

Citations

370

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Roles and appointments

Site Director, JDMI at the Princess Margaret Cancer Centre; Division Head, Molecular Imaging

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium
European Journal of Human Genetics · 2026
Theranostic: A Primer for Radiologists.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes · 2026
Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026 · first author

All 142 publications

142 publications.

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

Farncombe KM, Sobotka JA, Aronson M, Basik M, Bombard Y, Born L, Cheifetz R, Clausen M, Coburn N, Dawson L

European Journal of Human Genetics20263 citationsOpen Access

DOI: 10.1038/s41431-026-02014-z

Theranostic: A Primer for Radiologists.

Mirshahvalad SA, Beheshti M, Metser U, Jiang DM, Wong R, Alrekhais I, Veit-Haibach P

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes20263 citationsOpen Access

DOI: 10.1177/08465371251338032 PMID: 40405808

Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.

Metser U, Bauman G, Rashid M, Mirshahvalad SA, Kohan A, Green B, Chan R, Hamilton R

Journal of nuclear medicine : official publication, Society of Nuclear Medicine20261 citationsFirst author

DOI: 10.2967/jnumed.126.272204 PMID: 41991335

Prognostic value of [18F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.

Mirshahvalad SA, Farag A, Sekine T, Kohan A, Mafeld S, Roche-Nagle G, Byrne J, Metser U, Tan K, Veit-Haibach P

European journal of nuclear medicine and molecular imaging20261 citations

DOI: 10.1007/s00259-025-07514-6 PMID: 40815391

Correction: Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Metser U, Dayes IS, Parpia S, Eisen AF, Hodgson N, Cil TD, George R, Blanchette P, Arnaout A, Chan A

British Journal of Cancer2026First authorOpen Access

DOI: 10.1038/s41416-026-03435-9

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Mirshahvalad SA, Kohan A, Kulanthaivelu R, Ortega C, Metser U, Hodgson D, Kridel R, Chen C, Bhella S, Veit-Haibach P

Scientific reports2026Open Access

DOI: 10.1038/s41598-026-36849-9 PMID: 41606040

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Farag A, Mirshahvalad SA, Ortega C, Tartaglia C, Veit-Haibach P, Metser U

Alzheimer's & dementia (Amsterdam, Netherlands)2026Senior authorOpen Access

DOI: 10.1002/dad2.70449 PMID: 42591921

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Metser U, Mirshahvalad SA, Murad V, Veit-Haibach P, Han E

Frontiers in oncology2026First authorOpen Access

DOI: 10.3389/fonc.2026.1916551 PMID: 42614260

Late recurrent renal cell carcinoma presenting as a solitary gallium-68 DOTATATE-avid pancreatic mass with polycythemia.

Albalawi M, Metser U, Ezzat S

JCEM case reports2026Open Access

DOI: 10.1210/jcemcr/luag062 PMID: 42022489

Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Metser U, Dayes IS, Parpia S, Eisen AF, Hodgson N, Cil TD, George R, Blanchette P, Arnaout A, Chan A

British Journal of Cancer2026First authorOpen Access

DOI: 10.1038/s41416-026-03362-9

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Ur Metser

Research

Latest papers

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

Theranostic: A Primer for Radiologists.

Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.

Prognostic value of [18F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.

Correction: Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Late recurrent renal cell carcinoma presenting as a solitary gallium-68 DOTATATE-avid pancreatic mass with polycythemia.

Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Frequent collaborators

Patrick Veit-Haibach

Alejandro Berlin

Glenn Bauman

David Hodgson

Antonio Finelli

Sangeet Ghai

Adam Farag

Nathan Perlis

Amit Singnurkar

Robert Kridel

Anthony Fyles

Jonathan Yeung

Adriano Dias

Kathy Han

Michael Milosevic

David Jaffray

Girish Kulkarni

Jaydeep Halankar

Gregory Pond

Mark Norman Levine

Ravi Mohan

Yas Moayedi

Stéphane Laframboise

Jonathan Wasserman

Rajni Patel

Ur Metser

Research

Latest papers

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

Theranostic: A Primer for Radiologists.

Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.

Prognostic value of [18F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.

Correction: Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Quantification of global gray matter amyloid-&#x3b2; plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Late recurrent renal cell carcinoma presenting as a solitary gallium-68 DOTATATE-avid pancreatic mass with polycythemia.

Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma

Frequent collaborators

Patrick Veit-Haibach

Alejandro Berlin

Glenn Bauman

David Hodgson

Antonio Finelli

Sangeet Ghai

Adam Farag

Nathan Perlis

Amit Singnurkar

Robert Kridel

Anthony Fyles

Jonathan Yeung

Adriano Dias

Kathy Han

Michael Milosevic

David Jaffray

Girish Kulkarni

Jaydeep Halankar

Gregory Pond

Mark Norman Levine

Ravi Mohan

Yas Moayedi

Stéphane Laframboise

Jonathan Wasserman

Rajni Patel

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.